Reply to Pandey et al.: Understanding the efficacy of a potential antiretroviral drug candidate in humanized mouse model of HIV infection
Proc Natl Acad Sci U S A
.
2018 Aug 28;115(35):E8114-E8115.
doi: 10.1073/pnas.1810136115.
Epub 2018 Aug 10.
Authors
Shalley N Kudalkar
1
2
,
Jagadish Beloor
3
,
Elias Quijano
4
,
Krasimir A Spasov
1
2
,
Won-Gil Lee
5
,
José A Cisneros
5
,
W Mark Saltzman
4
,
Priti Kumar
3
,
William L Jorgensen
6
,
Karen S Anderson
1
2
Affiliations
1
Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520-8066.
2
Department of Molecular Biophysics and Biochemistry, Yale University School of Medicine, New Haven, CT 06520-8066.
3
Department of Internal Medicine, Section of Infectious Diseases, Yale University School of Medicine, New Haven, CT 06520.
4
Department of Biomedical Engineering, Yale University, New Haven, CT 06511.
5
Department of Chemistry, Yale University, New Haven, CT 06520-8107.
6
Department of Chemistry, Yale University, New Haven, CT 06520-8107 william.jorgensen@yale.edu.
PMID:
30097540
PMCID:
PMC6126721
DOI:
10.1073/pnas.1810136115
No abstract available
Publication types
Letter
Comment
MeSH terms
Animals
Anti-HIV Agents
Disease Models, Animal
HIV Infections*
HIV-1*
Mice
Substances
Anti-HIV Agents
Grants and funding
R01 AI112443/AI/NIAID NIH HHS/United States
T32 GM007223/GM/NIGMS NIH HHS/United States